|
LRMR Larimar Therapeutics Inc 1374690 |
| Balance Sheet |
|
Current Assets
|
213,256,000 |
|
Assets
|
219,021,000 |
|
Current Liabilities
|
16,285,000 |
|
Liabilities
|
20,621,000 |
|
Equity
|
198,400,000 |
|
Shares Out
|
103,883,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-48,945,000 |
|
Investing Cash Flow
|
-104,584,000 |
| Market Analysis |
Market Cap
|
473,706,018 |
|
Price
|
4.56 |
|
BVPS
|
3.11 |
|
PB
|
0.82 |
|
EPS
|
-2.27 |
|
PS
|
3.72 |
|
FCF
|
-153,529,000 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/30 |
-0.24 |
11/12 |
|
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LRMR documents filed with the SEC.
LRMR Filings
Clear
